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Background
The prevalence of peanut allergy is increasing. The reasons
for this are not entirely known. A factor may be vitamin D
(Vit D).
Methods
This study was performed in a referral allergist’s office in
Ontario. Prospectively, all patients (<18 years old) with
peanut allergy who were tested for peanut specific IgE (PN
IgE) also had Vit D measured. All measurements were
done between December 2010 and May 2011. The Vit D
measure was 25-hydroxy vitamin D. Patients were divided
into three groups: deficient (less than 25 nmol/L), insuffi-
cient (25-75 nmol/L) and sufficient (75-250 nmol/L). Vit
D levels were compared to PN IgE, sex, age, body mass
index (BMI) and other allergies.
Results
Fifty peanut allergic patients were included. The mean Vit
D level of the patients was 73.8 nmol/L and the 95% confi-
dence interval was 69.6 - 75.7 nmol/L. One patient (2%)
had deficient and thirty-one (62%) of the patients had
insufficient Vit D levels. Nineteen (38%) had Vit D levels
in the sufficient range. There was no correlation between
Vit D levels and PN IgE or BMI. Generalized linear model-
ing showed that vit D levels were predicted by age and sex
(p=0.04 & p=0.002, respectively).
Conclusions
Two percent of our patients had deficient Vit D levels
while 62% of our patients had insufficient Vit D levels.
These levels were statistically associated with age and sex.
Insufficiency of Vit D may play a role in peanut allergy.
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